In.Pact Admiral
Payments companies reported to CMS as associated with In.Pact Admiral. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with In.Pact Admiral, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with In.Pact Admiral
These are the largest totals companies reported as associated with In.Pact Admiral. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Schneider | Honolulu, HI | Vascular Surgery | $41,418.41 |
| Eric Scott | West Des Moines, IA | Vascular Surgery | $34,953.83 |
| John Winscott | Jackson, MS | Interventional Cardiology | $24,231.09 |
| Eric Secemsky | Boston, MA | Interventional Cardiology | $17,053.59 |
| Sanjeeva Kalva | Dallas, TX | Vascular & Interventional Radiology | $16,232.52 |
| Venita Chandra | Palo Alto, CA | Vascular Surgery | $14,733.52 |
| Sahil Parikh | New York, NY | Interventional Cardiology | $12,414.40 |
| Osama Ibrahim | Tullahoma, TN | Interventional Cardiology | $11,737.14 |
| Kenneth Rosenfield | Boston, MA | Cardiovascular Disease | $11,671.05 |
| Mehdi Shishehbor | Elyria, OH | Cardiovascular Disease | $11,593.53 |
Prescribed In.Pact Admiral?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.